Skip to main content
OpenTrials

Clinical trial condition

Recurrent Osteosarcoma

Explore clinical trials studying Recurrent Osteosarcoma. Study availability and eligibility vary by location and protocol.

52 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Osteosarcoma trial results

Completed

Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma

NCT02487979

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 155 locations
View Trial Details
Completed

Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma

NCT02097238

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 119 locations
View Trial Details
Completed

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01154816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hepatoblastoma, +33 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 105 locations
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

NCT01614795

Conditions
Childhood Alveolar Soft Part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, +34 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 76 locations
View Trial Details
Completed

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

NCT01016015

Conditions
Metastatic Osteosarcoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 24 locations
View Trial Details

Related conditions